150 related articles for article (PubMed ID: 35978057)
1. Upregulation of KLHL17 promotes the proliferation and migration of non-small cell lung cancer by activating the Ras/MAPK signaling pathway.
Liu Z; Zhao M; Jiang X; Zhang Y; Zhang S; Xu Y; Ren H; Su H; Wang H; Qiu X
Lab Invest; 2022 Dec; 102(12):1389-1399. PubMed ID: 35978057
[TBL] [Abstract][Full Text] [Related]
2. Aldolase A promotes proliferation and G
Fu H; Gao H; Qi X; Zhao L; Wu D; Bai Y; Li H; Liu X; Hu J; Shao S
Cancer Commun (Lond); 2018 May; 38(1):18. PubMed ID: 29764507
[TBL] [Abstract][Full Text] [Related]
3. ARMC8α promotes proliferation and invasion of non-small cell lung cancer cells by activating the canonical Wnt signaling pathway.
Xie C; Jiang G; Fan C; Zhang X; Zhang Y; Miao Y; Lin X; Wu J; Wang L; Liu Y; Yu J; Yang L; Zhang D; Xu K; Wang E
Tumour Biol; 2014 Sep; 35(9):8903-11. PubMed ID: 24894675
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of N-Acetylglucosaminyltransferase GCNT3 by miR-302b-3p Decreases Non-Small Cell Lung Cancer (NSCLC) Cell Proliferation, Migration and Invasion.
Li Q; Ran P; Zhang X; Guo X; Yuan Y; Dong T; Zhu B; Zheng S; Xiao C
Cell Physiol Biochem; 2018; 50(3):987-1004. PubMed ID: 30355927
[TBL] [Abstract][Full Text] [Related]
5. Ataxia-telangiectasia group D complementing gene (ATDC) promotes lung cancer cell proliferation by activating NF-κB pathway.
Tang ZP; Dong QZ; Cui QZ; Papavassiliou P; Wang ED; Wang EH
PLoS One; 2013; 8(6):e63676. PubMed ID: 23776433
[TBL] [Abstract][Full Text] [Related]
6. Sirtuin 7 promotes non‑small cell lung cancer progression by facilitating G1/S phase and epithelial‑mesenchymal transition and activating AKT and ERK1/2 signaling.
Zhao Y; Ye X; Chen R; Gao Q; Zhao D; Ling C; Qian Y; Xu C; Tao M; Xie Y
Oncol Rep; 2020 Sep; 44(3):959-972. PubMed ID: 32705247
[TBL] [Abstract][Full Text] [Related]
7. NOVA1 promotes NSCLC proliferation and invasion by activating Wnt/β-catenin signaling.
Qu L; Tian Y; Wang F; Li Z
BMC Cancer; 2022 Oct; 22(1):1091. PubMed ID: 36284263
[TBL] [Abstract][Full Text] [Related]
8. DDX5 promotes proliferation and tumorigenesis of non-small-cell lung cancer cells by activating β-catenin signaling pathway.
Wang Z; Luo Z; Zhou L; Li X; Jiang T; Fu E
Cancer Sci; 2015 Oct; 106(10):1303-12. PubMed ID: 26212035
[TBL] [Abstract][Full Text] [Related]
9. Cell adhesion molecule 4 suppresses cell growth and metastasis by inhibiting the Akt signaling pathway in non-small cell lung cancer.
Luo F; Zhao Y; Liu J
Int J Biochem Cell Biol; 2020 Jun; 123():105750. PubMed ID: 32325280
[TBL] [Abstract][Full Text] [Related]
10. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y
Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094
[No Abstract] [Full Text] [Related]
11. Phosphatidylethanolamine-binding protein 4 promotes the epithelial-to-mesenchymal transition in non-small cell lung cancer cells by activating the sonic hedgehog signaling pathway.
Jian W; Bai Y; Li X; Kang J; Lei Y; Xue Y
J Cell Biochem; 2019 Apr; 120(4):5386-5395. PubMed ID: 30367510
[TBL] [Abstract][Full Text] [Related]
12. High Metastasis-Associated Lung Adenocarcinoma Transcript 1 (MALAT1) Expression Promotes Proliferation, Migration, and Invasion of Non-Small Cell Lung Cancer via ERK/Mitogen-Activated Protein Kinase (MAPK) Signaling Pathway.
Liu C; Li H; Jia J; Ruan X; Liu Y; Zhang X
Med Sci Monit; 2019 Jul; 25():5143-5149. PubMed ID: 31293277
[TBL] [Abstract][Full Text] [Related]
13. CBLL1 is highly expressed in non-small cell lung cancer and promotes cell proliferation and invasion.
Hui L; Zhang S; Wudu M; Ren H; Xu Y; Zhang Q; Qiu X
Thorac Cancer; 2019 Jun; 10(6):1479-1488. PubMed ID: 31124298
[TBL] [Abstract][Full Text] [Related]
14. DHX38 enhances proliferation, metastasis, and EMT progression in NSCLC through the G3BP1-mediated MAPK pathway.
Mi K; Zeng L; Chen Y; Ning J; Zhang S; Zhao P; Yang S
Cell Signal; 2024 Jan; 113():110962. PubMed ID: 37931691
[TBL] [Abstract][Full Text] [Related]
15. Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer.
Zhou Y; Li S; Li J; Wang D; Li Q
Cell Physiol Biochem; 2017; 42(4):1431-1446. PubMed ID: 28715819
[TBL] [Abstract][Full Text] [Related]
16. piR-651 promotes tumor formation in non-small cell lung carcinoma through the upregulation of cyclin D1 and CDK4.
Li D; Luo Y; Gao Y; Yang Y; Wang Y; Xu Y; Tan S; Zhang Y; Duan J; Yang Y
Int J Mol Med; 2016 Sep; 38(3):927-36. PubMed ID: 27431575
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of CRKL correlates with poor prognosis and cell proliferation in non-small cell lung cancer.
Wang Y; Dong QZ; Fu L; Stoecker M; Wang E; Wang EH
Mol Carcinog; 2013 Nov; 52(11):890-9. PubMed ID: 22753141
[TBL] [Abstract][Full Text] [Related]
18. GRWD1 promotes cell proliferation and migration in non-small cell lung cancer by activating the Notch pathway.
Wang Q; Ren H; Xu Y; Jiang J; Wudu M; Liu Z; Su H; Jiang X; Zhang Y; Zhang B; Qiu X
Exp Cell Res; 2020 Feb; 387(2):111806. PubMed ID: 31891681
[TBL] [Abstract][Full Text] [Related]
19. High expression of Collagen Triple Helix Repeat Containing 1 (CTHRC1) facilitates progression of oesophageal squamous cell carcinoma through MAPK/MEK/ERK/FRA-1 activation.
Wang C; Li Z; Shao F; Yang X; Feng X; Shi S; Gao Y; He J
J Exp Clin Cancer Res; 2017 Jun; 36(1):84. PubMed ID: 28645305
[TBL] [Abstract][Full Text] [Related]
20. ARHGEF39 promotes tumor progression via activation of Rac1/P38 MAPK/ATF2 signaling and predicts poor prognosis in non-small cell lung cancer patients.
Zhou H; Cai L; Zhang X; Li A; Miao Y; Li Q; Qiu X; Wang E
Lab Invest; 2018 May; 98(5):670-681. PubMed ID: 29382922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]